导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.82% | 4434/4773 |
| 近一周 | -2.98% | 4459/5465 |
| 近一月 | -4.94% | 3538/5421 |
| 近一季 | -2.47% | 1390/5231 |
| 近半年 | -16.17% | 4158/4920 |
| 近一年 | -26.03% | 4113/4394 |
| 近两年 | 43.73% | 1735/2954 |
| 近三年 | 1.77% | 1901/2253 |
| 成立以来 | 15.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.08% 4619/4961 |
-7.67% 3788/5312 |
- - |
- - |
| 2025 | 15.42% 2546/4813 |
1.92% 1518/3635 |
9.23% 294/4076 |
9.65% 3339/4524 |
-5.44% 3562/4813 |
| 2024 | 18.12% 625/3463 |
-9.10% 2267/2808 |
-12.69% 2609/3014 |
34.43% 79/3129 |
10.72% 256/3463 |
| 2023 | -0.03% 429/2656 |
24.75% 101/2280 |
-7.73% 1898/2385 |
-7.86% 1633/2515 |
-5.75% 1486/2655 |
| 2022 | -19.82% 904/2207 |
-13.68% 812/1919 |
-5.71% 1868/2016 |
-14.69% 1134/2113 |
15.48% 68/2208 |
| 2021 | 3.93% 597/1822 |
-8.73% 1093/1255 |
9.86% 517/1330 |
-4.72% 731/1466 |
8.78% 139/1822 |
| 2020 | - - |
- - |
- - |
-3.09% 1085/1164 |
-0.86% 1087/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 合煦智远金融科技指数(LOF)A VS. 长安沪深300非周期A(740101) |